絞り込み

16731

広告

Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).

著者 Alikhan R , Bedenis R , Cohen AT
Cochrane Database Syst Rev.2014 May 7 ; 5():CD003747.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (74view , 0users)

Full Text Sources

Medical

Miscellaneous

Venous thromboembolic disease has been extensively studied in surgical patients. The benefit of thromboprophylaxis is now generally accepted, but it is medical patients who make up the greater proportion of the hospital population. Medical patients differ from surgical patients with regard to their health and the pathogenesis of thromboembolism and the impact that preventative measures can have. The extensive experience from thromboprophylaxis studies in surgical patients is therefore not necessarily applicable to non-surgical patients. This is an update of a review first published in 2009.
PMID: 24804622 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード